[1. Classification and staging of malignant tumors in female pelvis (no authors listed). Acta Obstet Gynecol Scand. 1971; 50:1-7.10.3109/00016347109157278]Search in Google Scholar
[2. Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol. 2005; 123 (Suppl); s13-s57.10.1309/J6PXXK1HQJAEBVPM]Search in Google Scholar
[3. Tinelli R, Tinelli A, Tinelli FG, Cicinelli E, Malvasi A. Conservative surgery for borderline ovarian tumors: a reviews. Gynecol Oncol. 2006; 100:185-91. Epub 2005 Oct 10.10.1016/j.ygyno.2005.09.021]Open DOISearch in Google Scholar
[4. Ozols RF, Rubin FC, Thomas GM. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, editors. Principle and practice of gynecologic oncology, 4th ed. Philadelphia, Pennsylvania, USA: Lippincott Williams & Wilkins; 2005: p. 539-57.]Search in Google Scholar
[5. FIGO (International Federation of Gynecology and Obstetrics) annual report on the results of treatment in gynecological cancer. [No authors listed]. Int J Gynaecol Obstet. 2003; 83 Suppl 1:ix-xxii, 1-229.]Search in Google Scholar
[6. Hart WR, Norris HJ. Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer. 1973; 31:1031-45.10.1002/1097-0142(197305)31:5<1031::AID-CNCR2820310501>3.0.CO;2-7]Open DOISearch in Google Scholar
[7. Bell DA. Ovarian surface epithelial-stromal tumors. Hum Pathol. 1991; 22:750-62.10.1016/0046-8177(91)90205-4]Open DOISearch in Google Scholar
[8. Ronnett BM, Kajdacsy-Balla A, Gilks CB, Merino MJ, Silva E, Werness BA, et al. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol. 2004; 35:949-60.10.1016/j.humpath.2004.03.006]Open DOISearch in Google Scholar
[9. Bj rge T, Engeland A, Hansen S, Trope CG. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993. Int J Cancer. 1997; 71: 780-6.10.1002/(SICI)1097-0215(19970529)71:5<780::AID-IJC15>3.0.CO;2-C]Search in Google Scholar
[10. Ayhan A, Guven S, Guven ES, Kucukali T. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors? Acta Obstet Gynecol Scand. 2007; 86:484-90.10.1080/00016340701226138]Open DOISearch in Google Scholar
[11. Trop_ C, Kaern J, Vergote IB, Kristensen G, Abeler V. Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors. Gynecol Oncol. 1993; 51: 236-43.10.1006/gyno.1993.1279]Open DOISearch in Google Scholar
[12. Morice P, Camatte S, Rey A, Atallah D, Lhomm_ C, Pautier P, et al. Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. Ann Oncol. 2003; 14:592-8.10.1093/annonc/mdg173]Open DOISearch in Google Scholar
[13. Kayikcioglu F, Pato O, Cengiz S, Tulunay G, Boran N, Yalvac S, et al. Accuracy of frozen section diagnosis in borderline ovarian malignancy. Gynecol Obstet Invest. 2000; 49:187-9.10.1159/00001024410729760]Open DOISearch in Google Scholar
[14. Houck K, Nikrui N, Duska L, Chang Y, Fuller AF, Bell D, et al. Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis. Obstet Gynecol. 2000; 95: 839-43.10.1097/00006250-200006000-00011]Search in Google Scholar
[15. Menzin AW, Rubin SC, Noumoff JS, LiVolsi VA. The accuracy of a frozen section diagnosis of borderline ovarian malignancy. Gynecol Oncol. 1995; 59:183-5.10.1006/gyno.1995.00047590469]Open DOISearch in Google Scholar
[16. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol. 1996; 20: 1331-45.10.1097/00000478-199611000-000048898837]Open DOISearch in Google Scholar
[17. Cadron I, Leunen K, Van Gorp T, Amant F, Neven P, Vergote I. Management of borderline ovarian neoplasms. J Clin Oncol. 2007; 25:2928-37.10.1200/JCO.2007.10.807617617524]Open DOISearch in Google Scholar
[18. Cheng B, Wan X, Qian X, Lv W, Xie X. Results of conservative surgery for recurrent borderline ovarian tumors. Eur J Gynaecol Oncol. 2009; 30:75-8.]Search in Google Scholar
[19. Fauvet R, Poncelet C, Boccara J, Descamps P, Fondrinier E, Dara_ E. Fertility after conservative treatment for borderline tumours: a French multicenter study. Fertil Steril. 2005; 83:284-90.10.1016/j.fertnstert.2004.10.00915705364]Open DOISearch in Google Scholar
[20. Kurman RJ, Trimble CL. The behavior of serous low malignant potential: Are they ever malignant? Int J Gynecol Pathol. 1993; 12:120-7.10.1097/00004347-199304000-000068463035]Open DOISearch in Google Scholar
[21. Norris HJ. Proliferative endometrioid tumors and endometrioid tumors of low malignant potential of the ovary. Int J Gynecol Pathol. 1993; 12:134-40.10.1097/00004347-199304000-00008]Open DOISearch in Google Scholar
[22. Suh-Burgmann E. Long-term outcomes following conservative surgery for borderline tumor or the ovary: a large population- based study. Gynecol Oncol. 2006; 103:841-7.10.1016/j.ygyno.2006.05.01416793124]Open DOISearch in Google Scholar
[23. Trimble CL, Kosary C, Trimble EL. Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol. 2002; 86: 34-7. 10.1006/gyno.2002.671112079297]Open DOISearch in Google Scholar